Perrigo Company plc (NYSE:PRGO - Get Free Report) declared a quarterly dividend on Wednesday, July 30th, RTT News reports. Stockholders of record on Friday, August 29th will be given a dividend of 0.29 per share on Tuesday, September 16th. This represents a c) annualized dividend and a dividend yield of 4.3%. The ex-dividend date of this dividend is Friday, August 29th.
Perrigo has a payout ratio of 35.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 37.9%.
Perrigo Stock Up 0.1%
Shares of PRGO stock traded up $0.02 during mid-day trading on Friday, hitting $26.69. The company's stock had a trading volume of 1,115,239 shares, compared to its average volume of 864,587. Perrigo has a 52-week low of $23.14 and a 52-week high of $30.93. The business has a 50-day moving average price of $27.01 and a 200 day moving average price of $26.30. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.28 and a current ratio of 2.36. The stock has a market cap of $3.67 billion, a price-to-earnings ratio of -20.37 and a beta of 0.47.
Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.04. Perrigo had a positive return on equity of 8.93% and a negative net margin of 4.16%. The firm had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $1.09 billion. During the same quarter in the previous year, the business earned $0.29 earnings per share. The company's revenue was down 3.5% on a year-over-year basis. Research analysts predict that Perrigo will post 2.56 EPS for the current fiscal year.
Perrigo Company Profile
(
Get Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.